Tagged with Egis

3 Key Takeaways from Europe’s Premier Regulatory Conference
EU Pharma Legislation: An Opportunity to Rethink
New US ‘Biosecure Act’ to Target Chinese Biotechs WuXi and BGI
New EFPIA Board Tackles EU Pharma Legislation Reform
Making the EU Pharma Package Count for Smaller Companies
Launch Conditionality: What’s at Stake?
Romania: Europe’s Most Challenging Market for Generics?
Arina Gholmieh – General Manager, Egis Romania
Hungary’s First Steps into Digital Healthcare
Amendments to Russia’s Pharma Labeling Legislation: Uncertainty Still Abounds
Egis: Holding On To Hungarian Heritage
István Hodász – CEO, Egis
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here